GlassScriptPhysician profile
Julie Wiley
NPI 1861671687
$2,328.75
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,591 · 2022: $738.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $431.64 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.12 | 2021-2022 | |
| Amgen INC. | $242.05 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $225.82 | 2021-2022 | |
| Glaxosmithkline, LLC. | $160.16 | 2021-2022 | |
| Ibsa Pharma INC. | $125.00 | 2021 | |
| Si-Bone, INC. | $108.88 | 2022 | |
| Genzyme Corporation | $106.60 | 2021 | |
| Novo Nordisk INC | $103.98 | 2021 | |
| Xeris Pharmaceuticals, INC. | $84.66 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.93 | 2022 | |
| Corcept Therapeutics | $48.75 | 2021-2022 | |
| Mannkind Corporation | $47.53 | 2021 | |
| Merck Sharp & Dohme LLC | $36.14 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $33.93 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $33.86 | 2022 | |
| Radius Health, INC. | $28.33 | 2021 | |
| Alexion Pharmaceuticals, INC. | $27.64 | 2021 | |
| Becton, Dickinson and Company | $26.45 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.33 | 2021 | |
| Clarus Therapeutics INC. | $22.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.27 | 2022 | |
| Kaleo, INC. | $18.76 | 2021 | |
| Tandem Diabetes Care, INC. | $17.86 | 2022 | |
| Dexcom, INC. | $15.34 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.41 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.